| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sam Williams, Ahmed El-Medany, Angus Nightingale, Yasmin Ismai. Rare presentation of Fabry disease as 'burnt-out' hypertrophic cardiomyopathy. BMJ case reports. vol 14. issue 9. 2021-09-07. PMID:34479887. |
rare presentation of fabry disease as 'burnt-out' hypertrophic cardiomyopathy. |
2021-09-07 |
2023-08-13 |
Not clear |
| Maheedhar Gedela, Rakshya Sharma, Kristin DeBerg, Christopher Stanto. Application of Genetic Testing in Unveiling the Diagnosis of Fabry Disease in a Patient with Hypertrophic Cardiomyopathy. South Dakota medicine : the journal of the South Dakota State Medical Association. vol 74. issue 4. 2021-08-27. PMID:34432960. |
application of genetic testing in unveiling the diagnosis of fabry disease in a patient with hypertrophic cardiomyopathy. |
2021-08-27 |
2023-08-13 |
Not clear |
| Costantina Prota, Donatella Ferraioli, Giuseppe Iuliano, Martina Pucci, Ilaria Radano, Pompea Bottiglieri, Valentina Favalli, Federico Pieruzzi, Gennaro Galasso, Carmine Vecchione, Rodolfo Citr. A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients. Journal of cardiovascular medicine (Hagerstown, Md.). vol 22. issue 1. 2021-08-17. PMID:33283995. |
a novel missense mutation for fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients. |
2021-08-17 |
2023-08-13 |
Not clear |
| Yüksel Çavuşoğlu, Ebru Özpelit, Nur Arslan, Mesut Demir, Gökhan Kahveci, Hüseyin Onay, Emir Özgür Barış Ökçün, Omaç Tufekcioglu, Selcen Yakar Tülüce, Gonca Kılıç Yıldırı. [Fabry disease in cardiology: Diagnosis and therapeutic approaches]. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir. vol 48. issue Suppl 2. 2021-08-09. PMID:33476309. |
however, in clinical practice, ventricular hypertrophy is usually thought to be due to hypertrophic cardiomyopathy in the absence of hypertension or aortic stenosis and fabry disease is often undiagnosed or overlooked. |
2021-08-09 |
2023-08-13 |
Not clear |
| João B Augusto, Nicolas Johner, Dipen Shah, Sabrina Nordin, Kristopher D Knott, Stefania Rosmini, Clement Lau, Mashael Alfarih, Rebecca Hughes, Andreas Seraphim, Ravi Vijapurapu, Anish Bhuva, Linda Lin, Natalia Ojrzyńska, Tarekegn Geberhiwot, Gabriella Captur, Uma Ramaswami, Richard P Steeds, Rebecca Kozor, Derralynn Hughes, James C Moon, Mehdi Namda. The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage. European heart journal. Cardiovascular Imaging. vol 22. issue 7. 2021-08-05. PMID:32514567. |
cardiac involvement in fabry disease (fd) occurs prior to left ventricular hypertrophy (lvh) and is characterized by low myocardial native t1 with sphingolipid storage reflected by cardiovascular magnetic resonance (cmr) and electrocardiogram (ecg) changes. |
2021-08-05 |
2023-08-13 |
Not clear |
| Francesca Graziani, Rosa Lillo, Elena Panaioli, Gionata Spagnoletti, Maurizio Pieroni, Paolo Ferrazzi, Antonia Camporeale, Elena Verrecchia, Ludovico Luca Sicignano, Raffaele Manna, Filippo Cre. Evidence of evolution towards left midventricular obstruction in severe Anderson-Fabry cardiomyopathy. ESC heart failure. vol 8. issue 1. 2021-07-01. PMID:33211404. |
in our population of patients with fabry disease and severe left ventricular hypertrophy (lvh) at the time of diagnosis, we observed an evolution towards a midventricular obstructive phenotype. |
2021-07-01 |
2023-08-13 |
Not clear |
| Cristina Chimenti, Romina Verardo, Andrea Frustac. Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease. Orphanet journal of rare diseases. vol 16. issue 1. 2021-06-28. PMID:33838691. |
hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with fabry disease. |
2021-06-28 |
2023-08-13 |
Not clear |
| Mustafa Yenerçağ, Uğur Arsla. Tp-e interval and Tp-e/QT ratio and their association with left ventricular diastolic dysfunction in Fabry disease without left ventricular hypertrophy. Journal of electrocardiology. vol 59. 2021-06-21. PMID:31945689. |
tp-e interval and tp-e/qt ratio and their association with left ventricular diastolic dysfunction in fabry disease without left ventricular hypertrophy. |
2021-06-21 |
2023-08-13 |
Not clear |
| Mustafa Yenerçağ, Uğur Arsla. Tp-e interval and Tp-e/QT ratio and their association with left ventricular diastolic dysfunction in Fabry disease without left ventricular hypertrophy. Journal of electrocardiology. vol 59. 2021-06-21. PMID:31945689. |
in the early stage of the fabry disease, diastolic dysfunction can occur before left ventricular hypertrophy (lvh). |
2021-06-21 |
2023-08-13 |
Not clear |
| Riccardo Vio, Annalisa Angelini, Cristina Basso, Alberto Cipriani, Alessandro Zorzi, Paola Melacini, Gaetano Thiene, Alessandra Rampazzo, Domenico Corrado, Chiara Calor. Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies. Journal of clinical medicine. vol 10. issue 9. 2021-06-05. PMID:34062949. |
to further complicate this scenario some infiltrative (amyloidosis) and storage diseases (fabry disease and glycogen storage diseases) may show either a hypertrophic or restrictive phenotype according to left ventricular wall thickness and filling pattern. |
2021-06-05 |
2023-08-13 |
Not clear |
| Yiting Fan, Tsz-Ngai Chan, Josie T Y Chow, Kevin K H Kam, Wai-Kin Chi, Joseph Y S Chan, Erik Fung, Mabel M P Tong, Jeffery K T Wong, Paul C L Choi, David K H Chan, Bun Sheng, Alex Pui-Wai Le. High Prevalence of Late-Onset Fabry Cardiomyopathy in a Cohort of 499 Non-Selective Patients with Left Ventricular Hypertrophy: The Asian Fabry Cardiomyopathy High-Risk Screening Study (ASIAN-FAME). Journal of clinical medicine. vol 10. issue 10. 2021-06-05. PMID:34067605. |
left ventricular hypertrophy (lvh) caused by cardiac variant fabry disease (fd) is typically late-onset and may mimic lvh caused by abnormal loading conditions. |
2021-06-05 |
2023-08-13 |
Not clear |
| Sandro Feriozzi, Ales Linhart, Uma Ramaswami, Vasiliki Kalampoki, Andrey Gurevich, Derralynn Hughe. Effects of Baseline Left Ventricular Hypertrophy and Decreased Renal Function on Cardiovascular and Renal Outcomes in Patients with Fabry Disease Treated with Agalsidase Alfa: A Fabry Outcome Survey Study. Clinical therapeutics. vol 42. issue 12. 2021-05-20. PMID:33218740. |
effects of baseline left ventricular hypertrophy and decreased renal function on cardiovascular and renal outcomes in patients with fabry disease treated with agalsidase alfa: a fabry outcome survey study. |
2021-05-20 |
2023-08-13 |
Not clear |
| Giulia De Angelis, Zoi Tsoumani, Anna Reid, Gaetano Nucifora, Richard Bruce Irwin, Matthias Schmit. Late-Onset Fabry Disease Presenting With Ventricular Tachycardia Originating From Typical Inferolateral Scar. The Canadian journal of cardiology. vol 36. issue 11. 2021-05-19. PMID:32407966. |
late-onset cardiac fabry disease is not uncommon among patients with unexplained left ventricular hypertrophy. |
2021-05-19 |
2023-08-13 |
Not clear |
| E Deborde, B Dubourg, S Bejar, A-C Brehin, S Normant, P Michelin, J-N Dache. Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping. Diagnostic and interventional imaging. vol 101. issue 2. 2021-02-17. PMID:31519470. |
differentiation between fabry disease and hypertrophic cardiomyopathy with cardiac t1 mapping. |
2021-02-17 |
2023-08-13 |
human |
| E Deborde, B Dubourg, S Bejar, A-C Brehin, S Normant, P Michelin, J-N Dache. Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping. Diagnostic and interventional imaging. vol 101. issue 2. 2021-02-17. PMID:31519470. |
to evaluate the potential of non-contrast myocardial t1 mapping on cardiovascular magnetic resonance examination (cmr) in differentiating patients with fabry disease (fd) from those with hypertrophic cardiomyopathy (hcm) and healthy control subjects. |
2021-02-17 |
2023-08-13 |
human |
| Anne-Louise Savary, Remy Morello, Carole Brasse-Lagnel, Paul Milliez, Soumeya Bekri, Fabien Labombard. Enhancing the diagnosis of fabry disease in cardiology with a targeted information: a before-after control-impact study. Open heart. vol 4. issue 1. 2021-01-12. PMID:28409012. |
cardiac complications in fabry disease are frequent and dominated by a high frequency of left ventricular hypertrophy; therefore, cardiologists may have an essential role in screening for this disease. |
2021-01-12 |
2023-08-13 |
Not clear |
| Martin Michaud, Wladimir Mauhin, Nadia Belmatoug, Roselyne Garnotel, Naiya Bedreddine, Florian Catros, Sophie Ancellin, Olivier Lidove, Francis Gache. When and How to Diagnose Fabry Disease in Clinical Pratice. The American journal of the medical sciences. vol 360. issue 6. 2020-12-29. PMID:32723516. |
symptoms and organ involvements of classical fabry disease are acral pain crisis, cornea verticillata, hypertrophic cardiomyopathy, stroke and chronic kidney disease with proteinuria. |
2020-12-29 |
2023-08-13 |
Not clear |
| Maria Fuller, Rebecca Perry, Madiha Saiedi, Janice M Fletcher, Joseph B Selvanayaga. Mono-symptomatic Fabry disease in a population with mild-to-moderate left ventricular hypertrophy. Molecular genetics and metabolism reports. vol 25. 2020-12-19. PMID:33335842. |
mono-symptomatic fabry disease in a population with mild-to-moderate left ventricular hypertrophy. |
2020-12-19 |
2023-08-13 |
Not clear |
| Jonathan D Dodd, Jonathon Leipsi. Cardiovascular CT and MRI in 2019: Review of Key Articles. Radiology. vol 297. issue 1. 2020-12-17. PMID:32749209. |
hypertrophic cardiomyopathy registries have revealed distinct clinical and mri phenotypes, highlighting different underlying causes, while others clarified the prognostic usefulness of mri in hypertrophic cardiomyopathy and fabry disease. |
2020-12-17 |
2023-08-13 |
Not clear |
| Chandu Sadasivan, Josie T Y Chow, Bun Sheng, David K H Chan, Yiting Fan, Paul C L Choi, Jeffrey K T Wong, Mabel M B Tong, Tsz-Ngai Chan, Erik Fung, Kevin K H Kam, Joseph Y S Chan, Wai-Kin Chi, D Ian Paterson, Manohara Senaratne, Neil Brass, Gavin Y Oudit, Alex P W Le. Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy. PloS one. vol 15. issue 9. 2020-11-18. PMID:32987398. |
screening for fabry disease in patients with unexplained left ventricular hypertrophy. |
2020-11-18 |
2023-08-13 |
human |